Explainer · July 16, 2026 · 5 min · By Darius Engelhardt
Masseter Botulinum Toxin vs Buccal Fat Removal: Two Very Different Routes to a Slimmer Lower Face
Both procedures are marketed as face slimming, but they act on different tissues, carry different risks, and suit different anatomies. Here is how clinicians actually decide between them.

Search interest in lower face slimming has grown steadily, and two procedures dominate the conversation: botulinum toxin injections into the masseter muscle and surgical removal of the buccal fat pad. They are frequently discussed as if they were interchangeable. They are not. They target different structures, produce different silhouettes, and fail in different ways when applied to the wrong candidate.
What each procedure actually does
The masseter is one of the primary muscles of mastication, running from the cheekbone down to the angle of the jaw. In some people, particularly those who clench, grind, or chew gum habitually, the muscle hypertrophies, meaning it grows larger with use, the same way a biceps does. When botulinum toxin is injected into the masseter, it blocks acetylcholine release at the neuromuscular junction. The muscle contracts less, and over roughly six to twelve weeks it atrophies, shrinking in bulk. The visible result is a narrower jaw angle when viewed from the front.
Buccal fat removal is surgical. The buccal fat pad sits deep in the mid to lower cheek, between the buccinator muscle and the masseter, in the hollow below the cheekbone. A surgeon makes a small incision inside the mouth and removes a portion of the pad. This reduces fullness in the lower cheek, creating a more sculpted, hollowed appearance below the cheekbones. It does nothing to the jaw angle itself.
Different tissues, different silhouettes
This is the core distinction. Masseter toxin narrows the face at the level of the jaw angle, which matters most for people whose lower face appears square or wide because of muscle bulk. Buccal fat removal reduces roundness in the mid to lower cheek, which matters most for people with genuinely full cheeks despite a stable adult body weight.
A useful clinical test for masseter hypertrophy is simple: clench the teeth and palpate the jaw angle. If a firm, prominent bulge appears and enlarges with clenching, muscle is the likely driver of width. If the lower face is soft and full without a clench-related change, fat or skeletal structure is more likely responsible, and toxin will not deliver the expected slimming.
Reversibility and permanence
Botulinum toxin is temporary. Effects typically last three to six months per session, with muscle bulk gradually returning if treatment stops. Many patients need two to three sessions in the first year before the contour change becomes obvious, since atrophy takes time. The temporary nature is a genuine advantage: if a patient dislikes the result, it fades.
Buccal fat removal is permanent, and this cuts both ways. The fat does not regenerate. Surgeons and dermatologists have raised a consistent concern in recent years: the buccal fat pad contributes to youthful midface fullness, and facial fat naturally diminishes with age. A face that looks pleasingly sculpted at 25 may look gaunt at 45 if too much fat was removed. This is why many surgeons now remove conservatively or decline patients with naturally lean faces altogether.
Risk profiles
Masseter toxin risks are mostly functional and transient. Overtreatment or imprecise placement can weaken chewing strength temporarily, affect the smile if toxin diffuses into the risorius or zygomaticus muscles, or cause asymmetry. There is also a phenomenon called paradoxical bulging, where superficial muscle fibers compensate, usually correctable with a follow-up dose. Repeated high-dose treatment over years may contribute to jowling in patients with lax skin, since muscle bulk was providing some structural support.
Buccal fat removal carries surgical risks: infection, hematoma, asymmetry, and injury to the parotid duct or branches of the facial nerve, both of which run near the operative field. These complications are uncommon in experienced hands but are not reversible in the way a toxin side effect is.
Cost and downtime
Toxin sessions involve essentially no downtime but require ongoing maintenance, so costs recur indefinitely. Buccal fat removal is a one-time cost with roughly one to two weeks of swelling, and the final contour may not settle for several months.
The myth worth flagging
A persistent claim online holds that either procedure will produce visible cheekbones or a defined jawline in anyone. Neither can. Bone structure sets the ceiling. Toxin reduces muscle that is enlarged, and surgery removes fat that is present in excess. In a patient whose lower face width is skeletal, driven by the mandible itself, both procedures underdeliver, and the honest recommendation may be no treatment, or a conversation about skeletal contouring, which is a far more involved intervention.
Bottom line
Ask what tissue is actually creating the fullness. Muscle that bulges on clenching points toward toxin, a reversible, repeatable option. True excess cheek fat in a weight-stable adult points toward conservative surgical reduction, with careful thought about how the face will age. A qualified injector or surgeon should be able to explain which structure they are targeting and why. If they cannot, that is the answer to keep looking.
Related reading: Buccal fat removal: the sculpted-cheek procedure.
More in Explainer
View all →- Masseter Botox or Buccal Fat Removal? Two Very Different Routes to a Slimmer Lower Face
- Masseter Slimming vs. Buccal Fat Removal: Two Very Different Ways to Narrow the Lower Face
- Masseter Botox vs. Buccal Fat Removal: Two Very Different Routes to a Slimmer Lower Face
- Buccal Fat Removal: Why the Same Procedure Slims One Face and Ages Another